Skip to content
Clinical Trials – home

Universitaetsklinikum Wuerzburg AöR

Verifiedinfo

Germany Straubmuehlweg 2a, Grombuehl, 97078 Wuerzburg, Germany

  • 150 trials recruiting
  • Plasma cell myeloma · Non-small cell lung cancer · Hidradenitis
  • Adults and children

About Specializations

Universitaetsklinikum Wuerzburg AöR in Wuerzburg, Germany specialises in clinical trials of conditions such as Plasma cell myeloma, Non-small cell lung cancer, Hidradenitis, Plasma cell myeloma refractory, and other specialisations. This site conducts important research.

Main research areas of the site

Diseases [C] - Cardiovascular Diseases [C14]

The Neurological Clinic and Polyclinic at Universitaetsklinikum Wuerzburg AöR is conducting clinical research in the area of cardiovascular diseases, with a strong focus on acute ischemic stroke and high-risk transient ischemic attack. These studies are designed to better understand how to reduce the chance of another stroke and improve care for people at elevated risk.

  • Evaluating new treatment options aimed at lowering the risk of recurrent ischemic stroke
  • Studying therapies for patients recovering from acute stroke or facing a high risk of transient ischemic attack
  • Assessing whether a new approach can outperform placebo in preventing future vascular events

This research reflects a focused effort to improve stroke prevention and treatment effectiveness in a major academic hospital setting in Wuerzburg.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Straubmuehlweg 2a, Grombuehl97078 WuerzburgGermany
Recruiting now
150 trials
Conditions studied
216
Partner status
Verified

More sites in WuerzburgGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

352 clinical trials

Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Exelixis Inc.
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:VISUGROMAB
  • Sponsor:CatalYm GmbH
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.